Effect of Pegylation on Self-Association of IFN-α2b

被引:0
|
作者
Mohs, Angela [1 ]
Ambrogelly, Alexandre [1 ]
Yang, Xiaoyu [1 ]
Haverick, Mark [1 ]
Cheung, Jason K. [1 ]
Narasimhan, Chakravarthy [1 ]
Shameem, Mohammed [1 ]
机构
[1] Merck Res Labs, Bioproc Dev, Kenilworth, NJ 07033 USA
关键词
protein pegylation; PEGIFN-alpha; 2b; PEG-intron; self-association; BS3; cross-linking; analytical centrifugation; MALDI-TOF; size exclusion HPLC; ULTRACENTRIFUGATION; INTERFERON-ALPHA-2B; HEMOGLOBIN;
D O I
10.1021/mp400343b
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pegylation of therapeutic proteins is an established technology used to enhance the bioavailability of an active pharmaceutical ingredient in the body of patients. While the physiochemical properties of pegylated monomeric proteins have been extensively described, there is still limited information on the characterization of pegylated oligomeric proteins. In this study, we report the characterization of a pegylated interferon alpha2b (PEGIFN-alpha 2b) concentration-dependent oligomerization by a series of orthogonal biochemical and biophysical methods. These methods include sedimentation velocity and sedimentation equilibrium analytical ultracentrifugation, Matrix-assisted laser desorption ionization, and size exclusion chromatography of bissulfosuccinimidyl suberate cross-linked PEGIFN. We report here that PEGIFN-alpha 2b self-associates in a concentration-dependent manner into mainly monomers, dimers, and trimers. In the presence of the chemical cross-linker, PEGIFN-alpha 2b is primarily monomeric (57%) at concentration lower than 0.3 mg/mL and contains about equal amount of monomers and dimers (47.0% and 37.7%, respectively), about 15% of trimers, and up to 4% of higher molecular weight species at 0.7 mg/mL and above.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 50 条
  • [1] Theoretical study on pegylation reaction mechanisms of IFN-α-2a, IFN-α-2b and IFN-β-1a
    Taqavian, Mohammad
    Abedi, Daryoush
    Zigheimat, Fatemeh
    Zeidabadinejad, Leila
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2017, 82 (7-8) : 841 - 850
  • [2] Regulation of gene expression by pegylated IFN-α2b and IFN-α2b in human peripheral blood mononuclear cells
    Brassard, DL
    Delorenzo, MM
    Cox, S
    Leaman, DW
    Sun, YP
    Ding, W
    Gavor, S
    Spond, J
    Goodsaid, F
    Bordens, R
    Grace, MJ
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2004, 24 (08): : 455 - 469
  • [3] Thermal stability of the WHO international standard of interferon alpha 2b (IFN-α2b):: Application of new reporter gene assay for IFN-α2b potency determinations
    Caserman, Simon
    Menart, Viktor
    Das, Rose Gaines
    Williams, Stella
    Meager, Anthony
    JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 319 (1-2) : 6 - 12
  • [4] IFN-α2b and IFN-β induce TRAIL-mediated NK cell cytotoxicity
    Iversen, AC
    Sundan, A
    Espevik, T
    FASEB JOURNAL, 2001, 15 (05): : A1027 - A1027
  • [5] Regression of infancy hemangiomas with recombinant IFN-α2b
    Garmendía, G
    Miranda, N
    Borroso, S
    Longchong, M
    Martínez, E
    Ferrero, J
    Porrero, P
    López-Saura, P
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (01): : 31 - 38
  • [7] Freeze-drying of HESylated IFNα-2b: Effect of HESylation on storage stability in comparison to PEGylation
    Liebner, Robert
    Bergmann, Sarah
    Hey, Thomas
    Winter, Gerhard
    Besheer, Ahmed
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 495 (01) : 608 - 611
  • [8] Role of interferon alpha 2b (IFN-α2b) in the treatment of conjunctive squamous neoplasia
    Diaz, Maria Dolores
    Boned, Ana
    del Buey, Maria Angeles
    Marco, Sara
    Lopez, Isabel
    Karlsruher, Gisela
    Montes, Paula
    Ascaso, Francisco Javier
    ACTA OPHTHALMOLOGICA, 2019, 97
  • [9] An update on pegylated IFN-α2b for the adjuvant treatment of melanoma
    Agarwala, Sanjiv S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (11) : 1449 - 1459
  • [10] Structural and biologic characterization of pegylated recombinant IFN-α2b
    Grace, M
    Youngster, S
    Gitlin, G
    Sydor, W
    Xie, L
    Westreich, L
    Jacobs, S
    Brassard, D
    Bausch, J
    Bordens, R
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2001, 21 (12): : 1103 - 1115